News
Piper Sandler Reiterates Overweight on NovoCure, Raises Price Target to $28
10 Apr 24
News, Price Target, Reiteration, Analyst Ratings
10 Health Care Stocks Whale Activity In Today's Session
3 Apr 24
Options
Wells Fargo Maintains Overweight on NovoCure, Lowers Price Target to $42
3 Apr 24
News, Price Target, Analyst Ratings
Peeling Back The Layers: Exploring NovoCure Through Analyst Insights
27 Mar 24
Analyst Ratings
HC Wainwright & Co. Maintains Neutral on NovoCure, Raises Price Target to $24
27 Mar 24
News, Price Target, Analyst Ratings
Novocure Stock Soars, Its Lung Cancer Electric Field Treatment Slows Progression To Brain, Data Shows
27 Mar 24
Biotech, News, Health Care, Movers, Trading Ideas, General
Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesday
27 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Novocure Announces METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating A Extension In Time To Intracranial Progression For Patients With Brain Metastases From Non-Small Cell Lung Cancer
27 Mar 24
Biotech, News, General
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
27 Mar 24
Movers
Market-Moving News for March 27th
27 Mar 24
Movers, Trading Ideas
HC Wainwright & Co. Reiterates Neutral on NovoCure, Maintains $22 Price Target
12 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Novocure Announced A Late Breaking Abstract That Reviews The Results Of An Exploratory Subgroup Analysis Of The Phase 3 ENGOT-ov50/GOG-3029/INNOVATE-3 Trial Has Been Selected At The European Society On Gynecological Oncology 2024 Congress
11 Mar 24
Biotech, News, Health Care, General
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
27 Feb 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
HC Wainwright & Co. Maintains Buy on NovoCure, Raises Price Target to $22
22 Feb 24
News, Price Target, Analyst Ratings
NovoCure Q4 EPS $(0.45) Beats $(0.52) Estimate, Sales $133.78M Beat $131.19M Estimate
22 Feb 24
Earnings, News
Earnings Scheduled For February 22, 2024
22 Feb 24
Earnings
Press releases
Novocure Announces 20 Presentations On Tumor Treating Fields, Highlighting Preclinical Effects in Pancreatic Cancer and Immune Effects, at American Association for Cancer Research (AACR) Annual Meeting 2024
5 Apr 24
Press Releases
Zai Lab Partner Novocure Announces METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer
27 Mar 24
Press Releases
METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer
27 Mar 24
Press Releases
Novocure Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update
22 Feb 24
Press Releases